Probiotics are “good”, live bacteria that live naturally in your baby’s intestine and are vitally important for gut health. A probiotic also maintains the balance in gut flora and assists your baby’s digestive tract with numerous health-promoting activities.1a-c
Probiotics are versatile: not only do probiotics play an important role in your baby’s digestive functions but can also have an effect on immune related functions.1c Several studies have shown that infants and children, after using Reuterina® drops, experienced marked improvements in common baby ailments, specifically conditions such as colic,2a regurgitation,3a abdominal pain4a and constipation!5a
Reuterina® uses a specific strain of bacteria called Lactobacillus reuteri, a member of the Lactobacilli species of probiotics.6a,7a Studies have shown that, during sickness, the gut flora undergo changes and the number of good bacteria declines.3b,7b Further evidence has shown that the balance of these good bacteria is crucial in alleviating common baby ailments, such as colic,2a-c regurgitation,3a-c abdominal pain,4a,b diarrhoea7c and constipation.5a-c
The best probiotic will be one that has proven effects in the condition(s) you are preventing or treating;1d Reuterina® drops have many proven benefits.2a,3a,4a,5a,7a Reuterina® drops have been proven to have positive effects in babies, such as reducing crying in colicky babies,2a decreasing regurgitation in newborn infants3a as well as effectively helping babies with constipation5a and other abdominal-related pain disorders.4a
The specific strain of bacteria used in Reuterina®, Lactobacillus reuteri (Probiotic Strain DSM 17938), has been clinically validated in over 120 clinical trials and is sold commercially in over 90 countries worldwide.8
With just 5 drops a day, Reuterina® drops can be your probiotic for Life.6a-c
How Reuterina® works: Reuterina® and colic
Despite decades of research, the cause of colic remains uncertain.2e However, in recent years, the role of gut flora has come into focus.2b Clinical trials show that colicky infants tend to have lower amounts of lactobacilli flora in their gut than non-colicky babies.2b
Six clinical studies with Reuterina® drops have shown an overall positive benefit for colicky infants.2a,3a,9a,10a,11a,12a Reuterina® reduces the daily crying time and fussing time in colicky infants by up to 50 %.9a Reuterina® starts working within the first week9b,c and improves the quality of life for the family of a colicky baby.10c,d
How Reuterina works: Reuterina® and constipation
Chronic constipation causes an imbalance in your baby’s gut flora.5b Probiotics are used to restore this balance to the gut flora and treat constipation in babies.5c
Reuterina® has been clinically shown to treat constipation in infants and constipated babies, restoring normal bowel movements.5a,d
Scientific evidence has proven the effectiveness of using Reuterina® drops for common baby ailments, specifically conditions such as colic, regurgitation, abdominal pain and constipation!2a,3a,4a,5a Reuterina® is certainly a baby probiotic with multiple benefits, suitable for babies, kids and adults, for life!6b,c
- Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria, 1-4 October 2001.
- Savino F, et al. Crying time and RORy/FOXP3 expression in Lactobacillus reuteri DSM 17938-treated infants with colic: A randomized trial. J Pediatr 2018;192:171-177.
- Indrio F, et al. Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation. A randomised clinical trial. JAMA Pediatr 2014;168:228-233.
- Weizman Z, et al. Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double-blind, placebo-controlled trial. J Pediatr 2016;174:160-164.
- Coccorullo P, et al. Lactobacillus reuteri (DSM 17938) in infants with Functional Chronic Constipation: A Double-Blind, Randomised, Placebo-controlled study. The Journal of Paediatrics 2010;157(4):598-602.
- Reuterina® drops Approved Package Insert, August 2009.
- Eom T-H, et al. The therapeutic effect of Lactobacillus reuteri in acute diarrhea in infants and toddlers. Korean J Ped 2005;48:986-989.
- Data on File.
- Chau K, et al. Probiotics for infantile colic: a randomized double-blind placebo controlled trial investigating Lactobacillus reuteri DSM 17938. J Pediatr 2014;166:74-78.
- Szajewska H et al. Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: A randomized, double-blind, placebo-controlled trial. J Pediatr 2013;162:257-262.
- Savino F, et al. Lactobacillus reuteri DSM 17 938 in infantile colic: A randomized, double-blind, placebo-controlled trial. Pediatrics 2010;126:e526-e533.
- Savino F, et al. Lactobacillus reuteri (American Type Culture Collection Strain 55730) Versus Simethicone in the Treatment of Infantile Colic: A Prospective Randomized Study. Am Acad Pediatrics 2007;119:e124. doi:10.1542/peds.2006-1222.